Half-life data in rodent plasma suggest rapid clearance consistent with most small unprotected peptides, though exact figures vary by study and measurement method
There appears to be no legal basis for selling BPC-157 as a drug, food, or a dietary supplement, and the Food and Drug Administration (FDA) confirmed there is also no legal basis for compounding pharmacies to use BPC-157 in compounded medications
Capsule format produced under cGMP-certified manufacturing standards with quality-focused production oversight
Tesamorelin has been extensively studied in the context of visceral adiposity reduction and body composition optimization
Once opened, exposure to air/oxygen increases oxidation risk, and using sterile technique (especially for reconstituted solution) is essential
Weight loss is a significant consideration for both medications, especially given the obesity epidemic and its association with conditions like Type 2 Diabetes